An open-label study of pemigatinib in cholangiocarcinoma: final results from FIGHT-202

Autor: Vogel, A., Sahai, V., Hollebecque, A., Vaccaro, G.M., Melisi, D., Al Rajabi, R.M., Paulson, A.S., Borad, M.J., Gallinson, D., Murphy, A.G., Oh, D.-Y., Dotan, E., Catenacci, D.V., Van Cutsem, E., Lihou, C.F., Zhen, H., Veronese, M.L., Abou-Alfa, G.K.
Zdroj: In ESMO Open June 2024 9(6)
Databáze: ScienceDirect